Nigellimine
CAS : 4594-02-9
Ref. 3D-EAA59402
| 1g | Arrêté | ||
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté |
Informations sur le produit
Nom :
Nigellimine
Synonymes :
- 1-Methyl-6,7-dimethoxyisoquinoline
- Isoquinoline, 6,7-Dimethoxy-1-Methyl-
- Isosalsolidine
- Nigellicimine
Description :
Nigellimine is a medicinal compound that has been shown to have potent anti-cancer properties. It is a kinase inhibitor that targets specific kinases involved in cancer cell proliferation and survival. Nigellimine is an analog of a compound found in Chinese black seed, and it has been shown to induce apoptosis (programmed cell death) in tumor cells. This compound has also demonstrated anticancer activity in animal studies, inhibiting the growth of cancer cells and reducing tumor size. Nigellimine is excreted in urine and has been shown to be safe for human consumption. Its potential as an anticancer therapy makes it a promising candidate for further research and development.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
203.24 g/mol
Formule :
C12H13NO2
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
